Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.10.3.1 (
tyrosinase
)
9,065
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Several nuclear factors that interact with sequences in the 5' flanking region of the mouse
tyrosinase
gene were identified using band shift and methylation interference assays. One of these factors bind to an AT-rich sequence, TATCAATTAG, located at -183 base pairs upstream of the transcription start site. To isolate cDNA clone encoding this DNA binding protein, we have screened a lambda gt11 cDNA expression library prepared from mouse melanocyte cell line with a labeled oligonucleotide probe containing its binding site. Complementary DNA clones encoding mouse high mobility group protein HMG-I and its isoform HMG-Y were obtained.
HMG-I(Y)
is a low molecular size, basic nuclear protein that binds specifically to AT-rich region of double-stranded DNA in vitro. In Northern blot analysis the level of
HMG-I(Y)
mRNA expression did not correlate with that of
tyrosinase
or TRP-1. Although the amount of
HMG-I(Y)
transcripts has no apparent influence on the mouse
tyrosinase
gene expression, it is possible that
HMG-I(Y)
binds to the 5' flanking sequence of the
tyrosinase
gene as an auxiliary factor, and facilitates the binding and activity of other transcription factors.
...
PMID:Identification of nuclear factors that bind to the mouse tyrosinase gene regulatory region. 788 99